Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Proteases >  Cysteine ??Protease Inhibitors >  Z-PHE-DL-ALA-FLUOROMETHYLKETONE

Z-PHE-DL-ALA-FLUOROMETHYLKETONE

Basic information Safety Supplier Related

Z-PHE-DL-ALA-FLUOROMETHYLKETONE Basic information

Product Name:
Z-PHE-DL-ALA-FLUOROMETHYLKETONE
Synonyms:
  • Z-PHE-DL-ALA-FLUOROMETHYLKETONE
  • Carbamic acid,N-[(1S)-2-[(3-fluoro-1-methyl-2-oxopropyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-,phenylmethyl ester
  • Nalpha-[(Benzyloxy)Carbonyl]-N-(4-Fluoro-3-Oxo-2-Butanyl)Phenylalaninamide z-fa-fmk
  • Nalpha-[(Benzyloxy)Carbonyl]-N-(4-Fluoro-3-Oxo-2-Butanyl)Phenylalaninamide
  • CS-1504
  • Z-Phe-DL-Ala-FMK
  • Benzyl ((2S)-1-((4-fluoro-3-oxobutan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate
  • SARS coronavirus,SARS-CoV,RRMs,DNA fragmentation,DEVDase,Caspase,Cathepsin,Inhibitor,externalization of phosphatidylserine,Apoptosis,inhibit,Z FA FMK,reovirus replication,ZFAFMK
CAS:
197855-65-5
MF:
C21H23FN2O4
MW:
386.42
Product Categories:
  • Inhibitors
  • API
Mol File:
197855-65-5.mol
More
Less

Z-PHE-DL-ALA-FLUOROMETHYLKETONE Chemical Properties

Boiling point:
630.5±55.0 °C(Predicted)
Density 
1?+-.0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,2-8°C
solubility 
DMF: 5 mg/ml; DMSO: 5 mg/ml
form 
White solid
pka
11.07±0.46(Predicted)
color 
White to off-white
More
Less

Safety Information

HS Code 
29145090
More
Less

Z-PHE-DL-ALA-FLUOROMETHYLKETONE Usage And Synthesis

Description

Z-FA-FMK is an irreversible inhibitor of cysteine proteases, including cathepsins B, L, and S, cruzain, and papain. It also inhibits effector caspases-2, -3, -6, and -7 (IC50 = 6-32 μM) without affecting the initiator caspases-8 and -10. Z-FA-FMK also modulates infection by certain bacteria, parasites, and viruses. It can be used both in cells and in vivo.

Uses

Z-FA-FMK is an irreversible cysteine protease inhibitor. It also inhibits papain and cruzain.

in vivo

Z-FA-FMK (1 mg/kg; intratumor injection; every 2 d, for 27 d; SCID mice with HT1080 xenograft) blocks reovirus infection in vivo[2].
Z-FA-FMK (8 mg/kg; i.v.; every 2 d, once; male BALB/c mice) markedly lessens the degree of impairment seen in D-GalN/TNF-α-induced kidney injury[3].

Animal Model:SCID mice with HT1080 xenograft (6-8 weeks)[2]
Dosage:1 mg/kg
Administration:Intratumor injection; every 2 days, for 27 days
Result:Blocked reovirus replication activity in both tumor and heart tissues.
Animal Model:Male BALB/c mice[3]
Dosage:8 mg/kg
Administration:Intravenous injection; once, 1 hour later, intraperitoneal injection D-GalN (700 mg/kg) and TNF-α (15 μg/kg).
Result:Decreased in the D-GalN/TNF-α-induced degenerative changes.
Decreased in the number of activated caspase-3-positive tubular epithelial cell.
Increased in kidney GSH levels, CAT, SOD and GPx activities and decreased in kidney LPO levels, LDH activity, serum AST and ALT activities, uric acid, and urea levels were determined.

IC 50

Cathepsin B; cathepsin L; Caspase-2; Caspase-3; Caspase-6; Caspase-7

Z-PHE-DL-ALA-FLUOROMETHYLKETONESupplier

Shanghai Zhengyi Pharmaceutical Co., Ltd Gold
Tel
17740884366
Email
derek1229@163.com
JIANGSU CURTIUS BIOTECH CO., LTD Gold
Tel
0513-89078808 13764678260
Email
1582941412@qq.com
Hangzhou Beiputai Biopharmaceutical Co., Ltd Gold
Tel
0571-85350119 15888826472
Email
bptsales@163.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com